ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

January 12, 1996

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

Estrogen Can Benefit Women With Metastatic Breast Cancer

January 30, 2009

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

July 18, 2008

NCI’s Future Depends On Recruiting Youth to Careers in Science, NCI Director Says at His Swearing-In Ceremony.

October 20, 2006